The estimated Net Worth of Elliot B Grossbard is at least 25.9 千$ dollars as of 29 May 2007. Elliot Grossbard owns over 2,000 units of Rigel Pharmaceuticals stock worth over 25,940$ and over the last 21 years Elliot sold RIGL stock worth over 0$.
Elliot has made over 1 trades of the Rigel Pharmaceuticals stock since 2007, according to the Form 4 filled with the SEC. Most recently Elliot bought 2,000 units of RIGL stock worth 19,360$ on 29 May 2007.
The largest trade Elliot's ever made was buying 2,000 units of Rigel Pharmaceuticals stock on 29 May 2007 worth over 19,360$. On average, Elliot trades about 105 units every 0 days since 2003. As of 29 May 2007 Elliot still owns at least 2,000 units of Rigel Pharmaceuticals stock.
You can see the complete history of Elliot Grossbard stock trades at the bottom of the page.
Elliot's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over 170,041,384$ worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth 7,281,949$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Ansbert Gadicke、Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of 961,207$. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth 16,552$.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: